Erwin Mombarg

Title: Erwin Mombarg: Innovator in Veterinary Vaccines

Introduction

Erwin Mombarg is a notable inventor based in Cuijk, Netherlands. He has made significant contributions to the field of veterinary medicine, particularly in the development of vaccines. His work focuses on enhancing the efficacy of vaccines through innovative compositions.

Latest Patents

Mombarg holds a patent for an aqueous composition comprising a biological antigen and an acrylic acid polymer. This invention is designed to provide an osmolarity higher than that of a 0.9% (w/v) sodium chloride solution in water. The composition is particularly relevant for use in a one-shot vaccine against porcine circovirus 2 (PCV2). Additionally, it aims to reduce fever induced by the biological antigens present when administered to subject animals.

Career Highlights

Erwin Mombarg is associated with Intervet International B.V., a company known for its commitment to animal health. His work at Intervet has allowed him to focus on innovative solutions that address critical challenges in veterinary medicine. Mombarg's expertise in vaccine development has positioned him as a key figure in the industry.

Collaborations

Mombarg collaborates with Theodorus Jansen, a fellow professional in the field. Their partnership exemplifies the importance of teamwork in advancing veterinary innovations.

Conclusion

Erwin Mombarg's contributions to veterinary vaccines highlight the significance of innovation in animal health. His patented aqueous composition represents a step forward in vaccine technology, showcasing his commitment to improving animal welfare.